A bill to amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes.
About This Bill
Committee
Latest Action · July 2, 2020
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S4228)